Literature DB >> 2947762

The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.

U Di Mario, D Q Borsey, G Contreas, C V Prowse, B F Clarke, D Andreani.   

Abstract

The possible correlation between soluble immune factors and platelet and coagulation factors has been evaluated in Type 1 diabetic patients with and without proliferative retinopathy, and in non-diabetic controls. Soluble immune complexes, platelet factor IV (PF4), beta-thromboglobulin, fibrinogen, factor VIII related antigen and anti-thrombin III were significantly increased in Type 1 diabetic patients with retinopathy as compared to non-diabetic controls. Fibrinogen and anti-thrombin III were also higher in those patients with retinopathy compared to those without retinopathy. A significant correlation was found between positive values of soluble immune complexes and increased levels of PF4 and beta-thromboglobulin in diabetic patients with retinopathy. The presence of soluble immune complexes and insulin-anti-insulin complexes was associated with a significantly greater number of elevated haemostatic factors in retinopathic patients. Our findings suggest that the interaction of platelets and soluble immune complexes or insulin-anti-insulin complexes may be pathologically relevant to the development of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947762      PMCID: PMC1542274     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Radioimmunoassay of fibrinopeptide A-clinical applications.

Authors:  C Kockum
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

2.  A radioimmunoassay for platelet factor 4.

Authors:  A E Bolton; C A Ludlam; D S Pepper; S Moore; J D Cash
Journal:  Thromb Res       Date:  1976-01       Impact factor: 3.944

3.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

4.  Three approaches to the radioimmunoassay of human beta-thromboglobulin.

Authors:  A E Bolton; C A Ludlam; S Moore; D S Pepper; J D Cash
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

5.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Anti-insulin-antibodies and late diabetic complications.

Authors:  O O Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

7.  Insulin--anti-insulin complexes.

Authors:  I Folling
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1976

8.  Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.

Authors:  F E Preston; J D Ward; B H Marcola; N R Porter; W R Timperley; B C O'Malley
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

9.  Plasma beta-thromboglobulin in diabetes mellitus.

Authors:  I W Campbell; J Dawes; D M Fraser; D S Pepper; B F Clarke; L J Duncan; J D Cash
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

10.  INSULIN-INDUCED GLOMERULOSCLEROSIS IN THE RABBIT.

Authors:  S C MOHOS; G R HENNIGAR; J A FOGELMAN
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

View more
  3 in total

1.  Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.

Authors:  A K H Lim; F Y Ma; D J Nikolic-Paterson; A R Kitching; M C Thomas; G H Tesch
Journal:  Diabetologia       Date:  2010-04-27       Impact factor: 10.122

2.  Fcγ receptor deficiency attenuates diabetic nephropathy.

Authors:  Virginia Lopez-Parra; Beñat Mallavia; Oscar Lopez-Franco; Guadalupe Ortiz-Muñoz; Ainhoa Oguiza; Carlota Recio; Julia Blanco; Falk Nimmerjahn; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

3.  Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis.

Authors:  Fanny Pineau; Davide Caimmi; Milena Magalhães; Enora Fremy; Abdillah Mohamed; Laurent Mely; Sylvie Leroy; Marlène Murris; Mireille Claustres; Raphael Chiron; Albertina De Sario
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.